Analysts at StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a note issued to investors on Sunday. The firm set a “sell” rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Trading Up 5.8 %
Shares of Aeterna Zentaris stock opened at $3.29 on Friday. The company’s fifty day simple moving average is $2.89 and its two-hundred day simple moving average is $3.26. The company has a market cap of $5.90 million, a P/E ratio of -0.22 and a beta of 1.55. Aeterna Zentaris has a 12-month low of $3.96 and a 12-month high of $12.00.
About Aeterna Zentaris
Featured Articles
- Five stocks we like better than Aeterna Zentaris
- What is the Dow Jones Industrial Average (DJIA)?
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What Makes a Stock a Good Dividend Stock?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Golden Cross Stocks: Pattern, Examples and Charts
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.